{
    "eid": "2-s2.0-85151964041",
    "title": "Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "cost-effectiveness analysis",
        "disparity",
        "economic evaluation",
        "equity",
        "immunization",
        "inequality",
        "vaccine"
    ],
    "authors": [
        "Chanthawat Patikorn",
        "Jeong Yeon Cho",
        "Philipp Lambach",
        "Raymond Hutubessy",
        "Nathorn Chaiyakunapruk"
    ],
    "citedby-count": 1,
    "ref-count": 38,
    "ref-list": [
        "European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment",
        "Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review",
        "Health gains and financial risk protection afforded by public financing of selected malaria interventions in Ethiopia: An extended cost-effectiveness analysis",
        "Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis",
        "Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis",
        "An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China",
        "Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system",
        "Health gains and financial risk protection: An extended cost-effectiveness analysis of treatment and prevention of diarrhoea in Ethiopia",
        "Health gains and financial protection from human papillomavirus vaccination in Ethiopia: Findings from a modelling study",
        "Public finance of rotavirus vaccination in India and Ethiopia: An extended cost-effectiveness analysis",
        "Using cost-effectiveness analysis to address health equity concerns",
        "Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review",
        "Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review",
        "Can cost-effectiveness analysis integrate concerns for equity? Systematic review",
        "Inclusion of equity in economic analyses of public health policies: Systematic review and future directions",
        "Incorporating health inequality impact into economic evaluation in low-and middle-income countries: A systematic review",
        "The PRISMA 2020 statement: An updated guideline for reporting systematic reviews",
        "Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration: A report of the ISPOR CHEERS II good practices task force",
        "Equity and specific populations",
        "Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria",
        "Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi",
        "Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand",
        "Model-based analyses to compare health and economic outcomes of cancer control: Inclusion of disparities",
        "Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness",
        "Estimated impact and cost-effectiveness of rotavirus vaccination in India: Effects of geographic and economic disparities",
        "Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People\u2019s Democratic Republic",
        "Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan",
        "Cost-effectiveness of adult pneumococcal vaccination policies in underserved minorities aged 50-64 years compared to the US general population",
        "Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old",
        "Distributional cost-effectiveness analysis in low- and middle-income countries: Illustrative example of rotavirus vaccination in Ethiopia",
        "Cost-effectiveness analysis of rotavirus vaccination in Argentina",
        "The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries",
        "Is the sustainable development goal target for financial risk protection in health realistic?",
        "Extended cost-effectiveness analysis for health policy assessment: A tutorial",
        "Distributional cost-effectiveness analysis: A tutorial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geneva",
            "@id": "60027142",
            "affilname": "Organisation Mondiale de la Sant\u00e9",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027142",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": null,
            "@id": "60014232",
            "affilname": "VA Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014232",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Salt Lake City",
            "@id": "60012445",
            "affilname": "University of Utah Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012445",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60007511",
            "affilname": "Sungkyunkwan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007511",
            "affiliation-country": "South Korea"
        }
    ],
    "funding": [
        "Department of Immunization, Vaccines and Biologicals",
        "World Health Organization",
        "IVB"
    ]
}